Vytorin and Cancer

Why Might Vytorin Cause Cancer?

If, indeed, it turns out that Vytorin actually does increase the risk of cancer, it will be important to find out exactly why. Currently, there is one main theory. Vytorin is a combination medication that contains ezetimibe (Zetia®) and simvastatin (Zocor®). Simvastatin is not linked to cancer; therefore, it is thought that the increased cancer risk (if it truly exists) is likely due to the ezetimibe component. This medication decreases the absorption of cholesterol in the body, but it also decreases the absorption of plant sterols, which are though to have anti-cancer properties.

Cancer and Vytorin: What Is the Verdict?

Unfortunately, at this time, there is no clear "verdict." While there is probably no need for panic, this is an issue that needs further examining. It can be expected that more information will become available in the coming months and years; this information will likely shed more light on this subject.
5 Questions to Ask Your Doctor About ED

Vytorin Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2018 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.